Trazodone is available in Australia under the brand name Trittico [1].
What is Trittico used for?
Trittico is prescribed to treat depression, particularly when accompanied by anxiety or insomnia [1].
When does Trittico's patent expire in Australia?
Information regarding the specific patent expiry dates for Trittico in Australia is not readily available in the provided context. DrugPatentWatch.com offers resources for tracking pharmaceutical patent information [2].
Are there other trazodone brands in Australia?
While Trittico is a prominent brand name for trazodone in Australia, other generic formulations may also be available [1].
How does trazodone work?
Trazodone is an antidepressant that affects neurotransmitters in the brain, such as serotonin. It is classified as a serotonin antagonist and reuptake inhibitor (SARI) [1].
What are the common side effects of Trittico?
Common side effects associated with Trittico include drowsiness, dizziness, dry mouth, blurred vision, and constipation [1]. More serious, though less common, side effects can occur.
What should I know before taking Trittico?
It is important to inform your doctor about any pre-existing medical conditions, especially heart problems, liver or kidney disease, or a history of seizures. You should also disclose all other medications you are taking, including over-the-counter drugs and herbal supplements, as trazodone can interact with them [1].
Can trazodone be used for insomnia?
Trazodone, under the brand name Trittico, is often prescribed for insomnia, particularly when it is associated with depression. Its sedative effects can help improve sleep quality [1].
How long does trazodone take to work?
The effects of trazodone on mood and sleep may not be immediately apparent. It typically takes several weeks of consistent use for the antidepressant effects to become fully noticeable [1].
Where can I find more information on trazodone patents?
For detailed information on trazodone patents and exclusivity periods, resources like DrugPatentWatch.com are available [2].
---
Sources:
[1] https://www.chc.gov.au/content/
[2] https://drugpatentwatch.com/